• Investors
  • About us
  • Innovation and Technology
  • News
  • Contact & Quotation Request
  • Careers
Logo polypeptidelogo polypeptide group 2logo polypeptide groupLogo polypeptide
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Generic peptides
  • Commercial Manufacturing
    • Commercial Products at PolyPeptide
    • Late Stage Development
    • Process Development and Optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Cosmetic
  • Individualized Peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Generic peptides
  • Commercial Manufacturing
    • Commercial Products at PolyPeptide
    • Late Stage Development
    • Process Development and Optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Cosmetic
  • Individualized Peptides
  • Oligos
  • Home
  • News
  • Business news
  • Efficient and sustainable solutions for large scale peptide manufacturing

Efficient and sustainable solutions for large scale peptide manufacturing

22 December 2021
Business news

We are happy to share the latest scientific publication from the PolyPeptide Innovation Team, Dr. Renan Revetti Duran, Innovation Scientist and Dr. Olivier Ludemann-Hombourger, Global Director, Innovation and Technology, in Chemistry Today, issue CO6-2021. Under the title “Efficient and sustainable solutions for large scale peptide manufacturing” they discuss peptide market trends, sometimes resulting in larger batch sizes and the need to adapt the manufacturing infrastructure for cost-effective, flexible and sustainable solutions. They also show how PolyPeptide Group is adapting its practices by promoting the greenest solutions for peptide manufacturing.

Read the article 

TKS – Chemistry Today CO6-2021

 

 

Back to news

Polypeptide Group

INFO

INVESTORS
CORPORATE NEWS
OUR STORIES
ABOUT US
MEDIA

CONTACT

CONTACT US
QUOTATION REQUEST
CAREERS

SOCIALS

LINKEDIN
FACEBOOK
TWITTER
YOUTUBE
© Confidentiality 2021 PolyPeptide Group • Cookie management • Personal data • Sitemap

ACTH (1-39) Porcine

Atosiban

Calcitonin

Carbetocin

Deslorelin

Desmopressin

Exenatide

Felypressin

Leuprolide

Liraglutide

Octreotide

PTH (1-34) Teriparatide

Semaglutide

Somatostatin

Triptorelin

Vasopressin, 8-L-Arginine

      By clicking “Accept”, you consent to the use of ALL the cookies on our website . However you may visit Cookie Settings to provide a controlled consent.
      Cookie settingsACCEPT
      Privacy & Cookies Policy

      Privacy Overview

      You can enable or disable your consent for each category of cookie.

      More information on the collection of personal data
      Necessary
      Always Enabled

      The necessary cookies help to make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

      Advertisement

      Marketing cookies are used to track visitors through websites. The goal is to display ads that are relevant and interesting to the individual user and therefore more valuable to third-party publishers and advertisers.

      Analytics

      Statistical cookies help website owners, through the anonymous collection and communication of information, to understand how visitors interact with websites.

      Performance

      Preferences cookies allow a website to retain information that changes the way the site behaves or displays, such as your preferred language or the region in which you are located.

      Save & Accept